Publications of M. Uhr
All genres
Journal Article (28)
2019
Journal Article
126 (11), p. 1559 - 1559 (2019)
A polygenic score of molecular sensitivity to GR-stimulation maps to stress related changes of the brains hemodynamic response function. JOURNAL OF NEURAL TRANSMISSION
Journal Article
126 (11), pp. 1519 - 1520 (2019)
A polygenic score of molecular sensitivity to GR-stimulation maps to stress related changes of the brains hemodynamic response function. JOURNAL OF NEURAL TRANSMISSION
Journal Article
20 (3), 485 (2019)
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Journal Article
100, pp. 254 - 263 (2019)
PTSD psychotherapy improves blood pressure but leaves HPA axis feedback sensitivity stable and unaffected: First evidence from a pre-post treatment study. PSYCHONEUROENDOCRINOLOGY
Journal Article
109, pp. 48 - 51 (2019)
abcb1ab p-glycoprotein is involved in the uptake of the novel antidepressant vortioxetine into the brain of mice. JOURNAL OF PSYCHIATRIC RESEARCH
Journal Article
90 (9), pp. 958 - 960 (2019)
Therapeutic Drug Monitoring in the Neuropsychopharmacology Summary of the Consensus Guidelines 2017 of the TDM-Working Group of the AGNP (vol 90, pg 463, 2018). SI
Journal Article
90 (5), pp. 463 - 471 (2019)
Therapeutic drugmonitoring in neuropsychopharmacology. Summary of the consensus guidelines 2017 of the TDM task force of the AGNP. NERVENARZT 2018
Journal Article
99 (2), pp. 389 - 403 (2018)
The Role of m6A/m-RNA Methylation in Stress Response Regulation. NEURON Meeting Abstract (7)
2023
Meeting Abstract
29, pp. 892 - 893. 9th Joint ECTRIMS-ACTRIMS meeting, Milan, ITALY, October 11, 2023 - October 13, 2023. (2023)
Serum interleukin 16 levels probed as predictor of longitudinal global and regional brain volume and lesion volume changes in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL, 2022
Meeting Abstract
55 (03), pp. 172 - 173. (2022)
The therapeutic reference range for olanzapine revised - how to combine old and new findings. In PHARMACOPSYCHIATRY, 2020
Meeting Abstract
21 (10), pp. 766 - 774. (2020)
Evidence for an enhanced procoagulant state in remitted major depression. In WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2019
Meeting Abstract
29, pp. S46 - S47. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, October 06, 2018 - October 09, 2018. (2019)
Perspective of personalised drug treatment in depression. In EUROPEAN NEUROPSYCHOPHARMACOLOGY,
Meeting Abstract
66 (1), p. 119 - 119. (2019)
Evidence of a prothrombotic Condition in Patients with a remitted Depression. In ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE,
Meeting Abstract
88, p. 134 - 134. 25th World Congress of the
International-College-of-Psychosomatic-Medicine (ICPM) on Psychosomatic
Medicine, Florence, ITALY, September 11, 2019 - September 13, 2019. (2019)
Evidence for an enhanced procoagulant state in remitted major depression. In PSYCHOTHERAPY AND PSYCHOSOMATICS,
Meeting Abstract
29, pp. S525 - S526. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, October 06, 2018 - October 09, 2018. (2019)
Cortisol response to nocturnal psychosocial stress in dependence of CRHR1 genotype. In EUROPEAN NEUROPSYCHOPHARMACOLOGY,